| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 1390 | Allopurinol | 0.0162638908166157 | 0.13080121 |
| NSC 158263 | Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8CI) | 0.0162638908166157 | 0.050599132 |
| NSC 175490 | Iron, carbonyl(.eta.5-2,4-cyclopentadien-1-yl)(di-4-morpholinylcarbamodithioato-S,S')- | 0.0162638908166157 | 0.061123341 |
| NSC 222722 | Null | 0.0162638908166157 | 0.26686383 |
| NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.0162638908166157 | 0.11464111 |
| NSC 328785 | ANTINEOPLASTIC-328785 | 0.0162638908166157 | 0.066251849 |
| NSC 33577 | Null | 0.0162638908166157 | 0.28127873 |
| NSC 335789 | 3-Azabicyclo[3.2.1]nonane-3-carbothioic acid, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide | 0.0162638908166157 | 0.17394752 |
| NSC 622070 | Null | 0.0162638908166157 | 0.21718626 |
| NSC 624358 | Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- | 0.0162638908166157 | 0.41430075 |